Evidence map›Paper›PMID 38560077›Full record

ArticleAmerican heart journal plus : cardiology research and practice2022

Self- vs provider-referral differences for coronary artery calcium testing.

Rebekah Lantz, Steve Young, Janet Lubov, Anas Ahmed, Ronald Markert, Srikanth Sadhu

Abstract read
In one paragraph

Article in American heart journal plus : cardiology research and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rebekah LantzWright State University Boonshoft School of Medicine, Internal Medicine Residency, Dayton, OH 45409, United States of America.
Steve YoungWright State University Boonshoft School of Medicine, Internal Medicine Residency, Dayton, OH 45409, United States of America.
Janet LubovWright State University Boonshoft School of Medicine, Fairborn, OH 45324, United States of America.
Anas AhmedWright State University Boonshoft School of Medicine, Internal Medicine Residency, Dayton, OH 45409, United States of America.
Ronald MarkertWright State University Boonshoft School of Medicine, Department of Internal Medicine and Neurology, Fairborn, OH 45324, United States of America.
Srikanth SadhuPremier Cardiovascular Institute, Interventional Cardiology, Premier Health, Dayton, OH 45409, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Study objectives: The objectives of this study were to identify independent predictors for moderate/accentuated coronary artery calcium (CAC) score and compare patients who self-referred for CAC Computed Tomography (CT) testing to those who were provider-referred. Design: Patients underwent CAC between January to July 2019. The analysis was divided into self-referred patients influenced by a CAC community campaign who identified themselves as having cardiovascular risk factors compared to provider-referred intermediate-risk patients who were asymptomatic. SAS version 9.4 (SAS Institute, Inc., Cary, NC) was used for all analyses. Setting: Seven southwest Ohio hospitals from a single network. Participants: 2124 adult patients who received CAC CT (163 self and 1961 provider-referred). Interventions: CAC CT. Main outcome measures: Demographics, risk factors, lab values, prescriptions, and referral status were used to compare CAC score differences between self- and provider-referred patients. Results: For 2124 patients, three predictors for moderate/accentuated CAC score remained significant after multiple logistic regression: CKD (OR 0.24, CI 0.008-0.68, Conclusions: CAC CT testing is associated with independent risk predictors and can be used to clarify cardiovascular risk in self- and provider-referred patients with statistical similarity. Patients reliably self-refer for CAC CT when risk is present during a community initiative. Such initiatives may have a preventive benefit and lead to earlier pursuit and optimization of anti-lipid therapies.

Indexed as

ASCVDCACCalcificationCoronaryHyperlipidemiaStatin

Identifiers

PMID38560077
PMCPMC10978187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.